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Objectives:Therapeutic hypothermia (32–34 ◦C) is recommended for comatose survivors of cardiac arrest;
however, the optimal technique for cooling is unknown. We aimed to compare therapeutic hypothermia
using either surface or endovascular techniques in terms of efficacy, complications and outcome.
Design: Retrospective cohort study.
Setting: Thirty-bed teaching hospital intensive care unit (ICU).
Patients:All patients (n=83) undergoing therapeutic hypothermia following cardiac arrest over a 2.5-year
period. Themean agewas 61±16 years; 88% of arrests occurred out of hospital, and 64%were ventricular
fibrillation/tachycardia.
Interventions: Therapeutic hypothermiawas initiated in the ICU using icedHartmann’s solution, followed
by either surface (n=41) or endovascular (n=42) cooling; choice of technique was based upon endovas-
cular device availability. The target temperature was 32–34 ◦C for 12–24h, followed by rewarming at a
rate of 0.25 ◦Ch−1.
Measurements and main results: Endovascular cooling provided a longer time within the target tempera-
ture range (p=0.02), less temperature fluctuation (p=0.003), better control during rewarming (0.04), and
a lower 48-h temperature load (p=0.008). Endovascular cooling also produced less cooling-associated
complications in termsof bothovercooling (p=0.05) and failure to reach the target temperature (p=0.04).
After adjustment for known confounders, there were no differences in outcome between the groups in
terms of ICU or hospital mortality, ventilator free days and neurological outcome.
Conclusion: Endovascular cooling provides better temperaturemanagement than surface cooling, as well
plica
a randas a more favorable com
requires confirmation in
. Introduction
Cardiovascular disease remains a leading cause of death in the
eveloped world and survival from cardiac arrest with good neu-
ological outcome is uncommon. In the United Kingdom less than
0% of patients admitted to the intensive care unit (ICU) following
ardiac arrest survive to hospital discharge1 and the majority of
hose who die do so as a result of neurological injury.2
Two prospective randomized controlled studies3,4 and a meta-
nalysis5 have shown benefit in survival and neurological outcome
ssociated with a 12–24h period of mild hypothermia (32–34 ◦C).
urrent guidance from the International Liaison Committee on
esuscitation is that therapeutic hypothermia (TH) should be insti-
 A Spanish translated version of the summary of this article appears as Appendix
n the final online version at doi:10.1016/j.resuscitation.2010.05.001.
∗ Corresponding author. +Tel.: +44 07976609165.
E-mail address: michael.gillies@nhs.net (M.A. Gillies).
300-9572/$ – see front matter © 2010 Elsevier Ireland Ltd. All rights reserved.
oi:10.1016/j.resuscitation.2010.05.001tion profile. The equivalence in outcome suggested by this small study
omized trial.
© 2010 Elsevier Ireland Ltd. All rights reserved.
tuted where possible for comatose survivors of cardiac arrest.6
Several controversies exist concerning TH, especially with regard
to the most efficient cooling technique, duration of hypothermia,
and patient selection.6
Therapeutic hypothermia can be induced rapidly by infusion
of cold (4 ◦C) crystalloid solution7 following which hypothermia
is maintained using either surface or endovascular techniques.
Surface cooling methods are effective but can be labor inten-
sive for the nursing staff and may prevent access to the patient.
Endovascular cooling is also effective and permits precise con-
trol of body temperature, but involves insertion of a large
(8.5 Fr) gauge catheter into the femoral vein, which is inva-
sive.
We have been using TH in our 30-bedded ICU (located within
a university affiliated, teaching hospital) since July 2005, employ-
ing both surface and endovascular cooling techniques. Our local
policy is that all cardiac arrests receive TH, irrespective of primary
rhythm or arrest location unless the patient has a contraindication.
We carried out a retrospective study on all patients undergoing TH
1 citation 81 (2010) 1117–1122
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ollowing cardiac arrest over a 30-month period, to address two
uestions:
1) Do endovascular or surface cooling techniques differ in effec-
tiveness, in termsof timespent at target temperature, induction
of cooling, re-warming and prevention of rebound hyperther-
mia?
2) Does choice of cooling technique affect incidence of complica-
tions or outcome?
. Materials and methods
A local research ethics committee reviewed the proposed study
nd waived the need for a full ethics submission, as the study met
he national criteria for service evaluation.
.1. Patient identification
Data were collected retrospectively on 83 patients undergoing
Hbetween July 2005 andDecember 2007. Patientswere identified
rom a prospective register of TH recipients, whichwas established
n July 2005prior to initiating THwithin the ICU.However to ensure
hat no TH recipients were inadvertently missed, we searched the
Carevue” ICU Database (Philips, UK) for all patients admitted with
ardiac arrest during this period and reviewed the case notes to
etermine if TH had been performed.
.2. Therapeutic hypothermia techniques
Patients were cooled according to our ICU protocol
Supplementary Figure). All patients received a 15–30ml/kg
olus of cold Hartmann’s solution to induce hypothermia as soon
s the decision to cool was made. One liter bags of Hartmann’s
olution were kept at 4 ◦C in fridges in the emergency department
nd on the ICU for this purpose. In all cases, core temperature was
onitored continuously using a bladder thermistor (Covidien AG,
ansfield, MA, USA). A temperature of 32–34 ◦C was targeted for
2–24h. In patients undergoing surface cooling, polythene bags
lled with ice slurry were applied to both sides of the neck, axillae,
roins, and under the knees. These were replaced as required
ntil the target temperature was reached. In the surface group
ewarming was allowed to occur passively with foil hats and use
f warm blankets. Active rewarming (i.e. with a heating device or
lanket) was not used. Two patients in the surface group under-
ent cooling with a cooling mattress and tent (Theracool, KCI
urope, Amstelveen, NL) and one with a cold water recirculation
ystem (Criticool System, Charter Kontron, Milton Keynes, UK). All
atients in the endovascular group had an Alsius ICY-Coolguard
Alsius Corp., Irvine, CA) inserted into the femoral artery. They
ere then cooled according to protocol for 12–24h with at target
emperature of 33±1 ◦C. No other cooling device or method was
sed. Re-warming was at 0.25 ◦Ch−1. Once re-warmed to 36 ◦C
he device was set to “fever” mode which attempts to prevent
ebound pyrexia. There was not a specific part of the protocol
elating to this; if shivering was a problem sedation was increased
nd neuromuscular blockers added. In the surface group the ice
lurry was replaced at frequent intervals, in the Alsius group it was
nsured that the power setting on the machine was at “MAX”.
From July 2005 until January 2006 surface cooling only was
ndertaken in our institution, however from January 2006 onwards
n increasing number of patientswere cooled using the endovascu-
ar system. By the start of 2007, surface cooling was only employed
f the ICY-Coolguard system was already in use on another patient
Fig. 1).Fig. 1. Distribution of cooling methods used. E refers to the period January through
June, and L to July through December.
2.3. Data collection
Patient demographic data included: age, weight, sex, and
APACHE II score. Details of cardiac arrest type, location and time
to return of spontaneous circulation (ROSC) were also recorded, as
were duration of ICU and hospital admission, duration of mechan-
ical ventilation, survival to ICU and hospital discharge and hospital
discharge location. Discharge to home was used as a surrogate for
good neurological outcome. Previous randomized controlled trials
have used Pittsburgh Cerebral Performance Criteria (CPC) grades
1–2 as a measure of good neurological outcome; in CPC 2 the
patient has some residual neurological impairment but can live
independently.3,4
Hourly temperatures for the first 72h from ICU admission were
collected. Although not every patient had a temperature recorded
during each hour (median number of hourly temperatures for the
group was 69/83, interquartile range 65/83 to 72/83), no patient
had more then 3h of consecutive missing temperature data. Tem-
perature during hours of missing data was estimated via linear
interpolation. Area under the temperature–time graph was calcu-
latedvia the trapezoid rule.Details of cooling-relatedcomplications
were also collected. Cooling-related complicationsweredefinedas:
symptomatic bradycardia (bradycardia requiring treatment with
atropine, sympathomimetics or pacing), cooling abandoned, tar-
get not reached (i.e. less than 12h spent below 34 ◦C), pancreatitis
(serum amylase >500 IU/L), new diagnosis of pneumonia in first 7
days (documented chest infection requiring treatment with antibi-
otics), bleeding or platelet transfusion and requirement for renal
replacement therapy. For the purpose of this analysis overcooling
(temperature less than 32 ◦C), and overshoot during re-warming
(temperature greater than 38 ◦C in the first 72h) were regarded as
complications. Phases of therapeutic hypothermia were defined as
follows: cooling phase was admission temperature until 34 ◦C was
reached, target rangewas32–34 ◦C, andrewarmingphase34–36 ◦C.
Patient demographic details, dates of ICU and hospital admis-
sion and discharge, status at discharge, duration of mechanical
ventilation and core temperature for the first 72h of ICU admis-
sionwere collectedbyquerying theCarevue (Phillips) ICUdatabase.
This was undertaken by our audit and databasemanagement team.
The remaining data were gathered by review of case notes and
electronic patient records.3. Statistical analysis
Between-group comparisons were made using Student’s t-test,
Fischer’s Exact Test and analysis of covariance where appropriate.
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Table 1
Patient demographics, cooling efficacy and outcome.
All patients Endovascular Surface p
Demographics
N 83 42 41
Age (years) 61.4±15.7 63.1±13.1 59.6±17.9 0.31
Female, n (%) 20 (24.1) 13 (31.0) 7 (17.1) 0.20
Weight (kg) 78.9±12.6 79.8±12.4 78.1±12.9 0.53
APACHE II 29.1±5.1 28.2±4.9 29.9±5.2 0.14
Cardiac arrest details
Out of hospital, n (%) 73 (87.5) 39 (92.9) 34 (82.9) 0.19
VF/VT, n (%) 53 (63.9) 32 (76.2) 21 (51.2) 0.02
Time to ROSC (min) 20.6±16.4 18.9±11.3 22.4±20.4 0.34
Cooling efficacy
Time to target temperature (h) 5.2±3.3 6.1±4.8 0.29
Time at target temperature (h) 22.4±6.1 17.5±12.3 0.02
Time to re-warm (h) 6.8±2.6 5.5±2.7 0.04
Area under 48-h temperature curve (◦Ch) 1661±33 1687±53 0.008
Average temperature fluctuation 10–20h (◦C) 1.0±0.8 1.7±1.3 0.003
Outcome measures
ICU mortality, n (%) 37 (44.6) 16 (38.1) 21 (51.2) 0.27
Hospital mortality, n (%) 45 (54.2) 21 (50.0) 24 (58.5) 0.51
ICU free days 9.7±10.2 9.7±9.8 9.6±10.7 0.97
Ventilator free days 10.6±10.7 10.9±10.4 10.2±11.2 0.76
Neurological outcome
N 83 42 41
Poor neurological outcome, n (%) 49 (59) 24 (57.1) 25 (61.0) 0.82
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Department and there was a higher starting temperature for the
endovascular group (36.2 ◦C versus 35.7 ◦C, Fig. 1). The endovas-
cular group spent significantly longer in the target range (22.4h
versus 17.5h; p=0.02) and re-warmed at a slower rate (p=0.04).
Table 2
Cooling-associated complications.
All patients Endovascular Surface p
N 83 42 41
Complication
Overcooling 15 (18%) 4 (10%) 11 (27%) 0.049
Overheat 37 (45%) 18 (43%) 19 (46%) 0.83
Target not
reached
13 (16%) 3 (7%) 10 (24%) 0.04
Cooling
abandoned
5 (6%) 2 (5%) 3 (7%) 0.68
Bradycardia 18 (22%) 10 (24%) 8 (20%) 0.79
Pancreatitis 0 (0%) NA NA NA
Pneumonia 49 (59%) 29 (69%) 20 (49%) 0.08
Bleeding 7 (8%) 6 (14%) 1 (2%) 0.11
Platelet
transfusion
3 (4%) 2 (5%) 1 (2%) 1.00PCPC 3.3±1.9
ata are mean (±SD) or count (%).
bbreviations: VF/VT, ventricular fibrillation/pulseless ventricular tachycardia; ROS
erformance Criteria.
omparison of binary outcomes (mortality, neurological outcome)
as via logistic regression. The variable selectionprocesswasmade
priori, basedupon important variables identified in the literature.6
hese included: cooling technique, APACHE II score, time to ROSC,
nd primary arrest rhythm (ventricular fibrillation/pulseless ven-
ricular tachycardia versus non-ventricular fibrillation/pulseless
entricular tachycardia). Multicollinearity was screened for using
he variance inflation factor, with an upper acceptable limit of 2.5.
he procedure for dealing with multicollinearity (if present) was
ariable exclusion. Interaction effects were not screened for. Rou-
ine goodness of fit tests and residual analyses were performed
examination of residual plots for delta-deviance, delta-dfitbeta,
ook’s distance, and the Hosmer Lemeshow test). Because small
ultivariable models typically produce over-inflated odds ratios
known as shrinkage), we estimated model shrinkage using the
euristic shrinkage estimator proposed by van Houwelingen and
e Cessie.8 This gives a global estimate of the model signal-to-
oise ratio, with values ≥0.80 being desirable (meaning that <20%
f the model is likely to be noise). Statistical analysis was car-
ied out using SPSS version 15 (SPSS, Chicago, IL) and Stata v11
Stata Corp., TX).
. Results
.1. Demographics and cardiac arrest details
A total of 83 patients receiving TH were identified, of which 42
nderwent endovascular cooling and the remaining 41 underwent
urface cooling. Between-group comparisons for demographics,
ardiac arrest details, primary outcomes and complications are
ummarized in Tables 1 and 2. The two groups were comparable in
ermsof age, sex,weight andAPACHE II scores. Themajority (87.5%)
f cardiac arrests was “out of hospital” and in 63.9% the primary
hythm was ventricular fibrillation or pulseless ventricular tachy-
ardia. Of note the proportion of ventricular fibrillation/pulseless
entricular tachycardia was higher in the endovascular group (76%3.2±1.9 3.5±1.9 0.55
rn of spontaneous circulation; ICU, intensive care unit; PCPC, Pittsburgh Cerebral
versus 51%, p=0.02). Time to return of spontaneous circulationwas
similar between the groups.
4.2. Cooling efficacy
Mean temperaturewith 95% confidence intervals for each group
from ICU admission until 72h is shown in Fig. 1. No difference
was observed in time taken to reach target temperature between
the two groups (Table 1); however this may have been influenced
by lead time bias as cooling was commenced in the EmergencyRenal
replacement
therapy
14 (17%) 5 (12%) 9 (22%) 0.25
Any
complication
73 (88%) 38 (91) 35 (85%) 0.52
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rror bars 95% confidence interval for the mean.
he area under the temperature–time curve over 48h was signifi-
antly less in the endovascular group (Table 1 and Fig. 2, p=0.008).
o exclude a learning effect (as the majority of patients in the first
alf of the studywere treatedby surface cooling),wealso compared
he area under the 48h temperature–time curve for the two cool-
ng methods after adjustment for study period (2005–2006, n=38
ersus 2007, n=45) using analysis of covariance. This confirmed
he superiority of endovascular cooling (p=0.003), with no obvi-
us time period effect (p=0.13). There was also less temperature
ariation in the endovascular group when compared between 10
nd 20h, when coolingwasmost likely to have been in steady state
s judged in Fig. 1 (1.0 ◦C versus 1.7 ◦C, p=0.003, Table 1).
.3. Complications
The surface cooling group had a higher incidence of overcooling
27% versus 10%, p=0.049) and inability to reach the cooling target
24% versus 7%, p=0.04). Therapeutic hypothermiawas abandoned
n 6% (n=5) overall, in almost equal proportions across the two
roups (p=0.68, Table 2). This was for haemodynamic instabil-
ty (n=3), hematemesis (n=1) and cardiogenic shock. Other than
his therewere no significant differences in complications between
able 3
ultivariable analysis of outcome measures.
Variable Odds ratio
ICU mortality (Hosmer Lemeshow X2 = 9.86, p=0.28, shrinkage=0.805)
Endovascular cooling 0.97
APACHE II* 1.17
Non-VF/VT 3.36
Time to ROSC** 1.01
Hospital mortality (Hosmer Lemeshow X2 = 3.46, p=0.90, shrinkage=0.787)
Endovascular cooling 1.24
APACHE II* 1.12
Non-VF/VT 5.46
Time to ROSC** 1.01
Poor neurological outcome (Hosmer Lemeshow X2 = 6.98, p=0.54, shrinkage=0.801)
Endovascular cooling 1.65
APACHE II* 1.09
Non-VF/VT 8.52
Time to ROSC** 1.01
bbreviations: VF, ventricular fibrillation; VT, pulseless ventricular tachycardia; ROSC, ret
* Odds ratio per one point increase in APACHE II score.
** Odds ratio per 1min increase in ROSC. In all models global shrinkage was approximan 81 (2010) 1117–1122
groups. The apparent increase in bleeding in endovascular group
(14% versus 2%) did not reach statistical significance (p=0.11). Of
the patients in the endovascular group who suffered bleeding one
was as a result of a traumatic pre-hospital intubation. The restwere
ooze or minor bleeding reported around the endovascular catheter
site.
4.4. Outcome measures
There was no difference in unadjusted ICU or hospital mortal-
ity, ICU-free days or ventilator-free days between groups (Table 1).
The unadjusted proportion with poor neurological outcome was
also similar. Multivariable analysis (Table 3) showed that two
factors were consistently associated with mortality: (a) a higher
APACHE II score and (b) cardiac arrests other than ventricu-
lar fibrillation/pulseless ventricular tachycardia. After adjustment
for potential confounders (Table 3), there was no difference in
ICU mortality, hospital mortality or neurological outcome with
endovascular compared to surface cooling.
5. Discussion
The role of TH in comatose survivors of cardiac arrest is
increasingly recognized,3–5 and there is increasing evidence that
a standardised approach including coronary revascularization and
therapeutic hypothermiamayenhance survival.9 Theoptimal tech-
nique for delivering TH is debatable; the International Liaison
CommitteeonResuscitation identifies “optimal cooling technique–
internal versus external” as a critical knowledge gap.6 In their 2008
consensus statement, the Committee recommends that tempera-
ture maintenance is best achieved with devices that incorporate
continuous temperature feedback.6 They highlight the potential
drawbacks of surface cooling using ice packs: increased labor
intensity, greater temperature fluctuations, and inability to under-
take controlled re-warming. This is despite the fact that, in both
prospective randomized controlled trials of therapeutic hypother-
mia, cooling with external application of ice packs was used.3,4 The
importance of timing, especially “time to target temperature” is
also controversial. Wolff et al. undertook multivariate regression
analysis on a group of 49 patients successfully resuscitated from
cardiac arrest and suggested that short time to target temperature
was an independent predictor of a good neurological outcome,10
however registry data from 975 patients collected between 2004
and 2008 found that factors related to the timing of TH had no
apparent association to outcome.11
(95% CI) p
(0.35–2.70) 0.96
(1.05–1.31) 0.004
(1.18–9.61) 0.02
(0.98–1.04) 0.38
(0.45–3.42) 0.68
(1.01–1.24) 0.03
(1.78–16.72) 0.003
(0.98–1.04) 0.60
(0.58–4.74) 0.35
(0.99–1.21) 0.10
(2.42–30.03) 0.001
(0.98–1.04) 0.60
urn of spontaneous circulation.
tely 0.80, illustrating an acceptable signal-to-noise ratio.
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Moreover the majority of reports to date have not involved
irect comparison of endovascular versus surface methods, but
ather documented the efficacy of TH using one of these two tech-
iques in isolation. A retrospective study found that approximately
wo-thirds (20/32) of patients undergoing TH with ice-packs
nd cooling blankets demonstrated overcooling (temperatures
32 ◦C).12 Conversely, endovascular temperature control has been
sed successfully in theneuro-ICU setting as early as 2002.13 Holzer
t al. compared 97 patients following cardiac arrest undergoing
H using an endovascular device with 941 control patients who
ad received standard therapy with normothermia over a 13-year
eriod. They found temperature control with the endovascular
evice to be safe and effective and associated with improved sur-
ival and short termneurological recovery compared to the control
roup.14
Two studies have compared various combinations of cooling
ethods. Flint et al.15 retrospectively evaluated endovascular cool-
ng when used as an adjunct to a surface method in 42 patients
ver 3.5 years. The combination of endovascular and surface cool-
ng provided better temperature control with less overcooling and
lower incidenceof bradycardia compared to surface cooling alone.
oedemaekers et al. compared five cooling methods in 50 patients
aiming for either TH or normothermia, dependent upon indica-
ion for cooling), and also found the endovascular technique more
fficacious.16
Our studyprovides a large single-centre comparisonof endovas-
ular versus surface cooling following cardiac arrest. Our patient
emographic is comparable to that reported by the European
esuscitation Council Hypothermia Registry, with a similar pro-
ortion of out of hospital cardiac arrest (87.5% versus 91%) and a
rst reported rhythm of ventricular fibrillation or pulseless ven-
ricular tachycardia (64% versus 68%).17 In terms of efficacy, we
ave shown that endovascular cooling appears superior to surface
ooling, providing a greater proportion of time in the target zone
32–34 ◦C) and better control during rewarming. The importance of
he latterfinding isbecause rapid rewarmingmaynegate thepoten-
ial benefits of TH.18 The cooling-associated complication rate was
lso more favorable for endovascular cooling, in terms of a lower
roportion of patients experiencing both overcooling and failing to
each the cooling target.However this didnot translate into adiffer-
nce in other temperature-influenced complications (bradycardia,
ancreatitis, etc.) between the groups. The efficacy and complica-
ion rate of endovascular cooling in our study is in accord with
revious reports.13–15
After adjustment for confounders, we could not demonstrate a
ifference in outcome between the groups; in terms of mortality,
CU stay or neurological status at discharge. Whether this repre-
ents true equivalence or a type 2 error is unknown. Two potential
ources of type 2 error in a retrospective study such as ours are
ailure to adjust for unknown confounders, and small sample size;
oth could only be addressed by a randomized control trial. One
uch potential confounder in the current study could be an unin-
ended change in our entry criteria for TH as time progressed,
eaning that we were offering TH to patients with different prog-
ostic profiles in the latter half of the study when endovascular
ooling was the preferred technique. This is consistent with (a) the
ncreased number of patients receiving TH in the second half of
he study (see Supplementary Figure 1), despite our overall ICU
dmission rate for cardiac arrest being unchanged, and (b) a higher
roportion of patients with VF/VT in the endovascular group. In
ddition, our relatively small sample size may also have resulted
n overfitting of the multivariable model; which typically gives
n inflated estimate of effect size.19 Although we attempted to
ccount for this by quantifying shrinkage, this may not compen-
ate fully for this phenomenon.19 Indeed, it is conceivable that
everal harmful effects may be associated with endovascular cool-
1
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ing. Patel et al. highlighted safety concerns about catheter-related
blood stream infections arising from endovascular cooling20;while
a recent study of efficacy and safety in 40 patients noted a six-
fold increase in nosocomial bacteremia compared with the general
ICU population.21 Again this is consistent with the higher (albeit
non-significant) rates of endovascular nosocomial pneumonia (69%
versus 49%) and bleeding (14% versus 2%) seen in our patients.
Our studyhas several limitations. Although the largest compara-
tive study of its kind, it is still small, retrospective anduncontrolled.
A possible source of bias is that patients undergoing surface cool-
ing were more likely to receive this technique during our first
18 months experience with TH; following this period endovascu-
lar cooling was the preferred technique, and surface cooling was
only undertaken if the Alsius Coolguard was already in use on
another patient. This may have resulted in a learning curve effect
for TH per se, thereby diminishing the apparent efficacy of surface
cooling. Lastly, TH was usually initiated on admission to ICU and
not at the site of cardiac arrest, which may decrease any survival
benefit.
6. Conclusion
Endovascular cooling appears more efficacious than surface
cooling in terms of temperature control for TH following cardiac
arrest; this is also associated with a better temperature-associated
complication profile. After adjustment for known confounders, we
wereunable to showadifference in outcomewith either technique.
This requires confirmation in a randomized control trial.
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